Drug Filter >
  • Company: Jiangsu Hengrui Medicine
  •   > 
Drug Filter
Category:
Chemicals (28) Biologics (3)
Status:
Approved (2) NDA Filing (2) Phase Ⅲ (7) Phase Ⅱ (6) Phase Ⅰ (13) IND Filing (1)
Clinical Stage:
Pending (4) Active (20) Discontinued (4)
Bio-Type:
Recombinant cytokines (1) Whole antibody (2)
Indication:
Acute myeloid Leukemia (AML) (1) Angina pectoris (1) Basal cell carcinoma (BCC) (1) Breast cancer (1) Colorectal disorder (1) Coronary artery disease (CAD) (1) Gastric cancer (2) Heart failure (1) Hypertension (1) Lung cancer (1) Melanoma (3) Metastatic gastric carcinoma (1) Osteoarthritis (OA) (1) Postoperative pain (1) Prostate cancer (1) Psoriasis (1) Rheumatoid arthritis (RA) (2) Solid tumours (6) Thrombocytopenia (1) Type 2 diabetes (5) Systemic bacterial infections (1) Chronic heart failure (1) Anesthesia (1) HER2-positive metastatic breast cancer (1) Neutropenia (1) Hematological cancer (2) Gout (1)
Aprv. Year:
2014 (1) 2011 (1)
Others:
Sort: Aprv. Year Alphabetical Prev Next
First Prev 1 2 Next Last GO
Recently Viewed Drugs:

CopyRight©2017药渡经纬信息科技(北京)有限公司 电子与信息服务业务经营许可证151001号

京ICP备14047345| 京公安网备11010802017043号 |(京)-经营性-2015-0023(互联网药品信息服务资格证书)

药渡APP Drug A-Z
药渡APP
药渡微信二维码
微信二维码